Difference between revisions of "Gail K. Naughton"
Jump to navigation
Jump to search
(Created page with "'''Gail K. Naughton''' was president and COO of Advanced Tissue Sciences, which produced a living skin product call Dermagraft used to help healing of diabetic foot ul...") |
WikiModEn2 (talk | contribs) (Add degrees.) |
||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | '''Gail K. Naughton''' was president and COO of [[Advanced Tissue Sciences]], which produced a living skin product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [ | + | '''Gail K. Naughton''', Ph.D., MBA, B.S., was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [https://www.takeda.com/newsroom/newsreleases/2019/takeda-completes-acquisition-of-shire-becoming-a-global-values-based-rd-driven-biopharmaceutical-leader/ Shire], a medical company based in Dublin, Ireland. |
| − | Naughton founded Histogen in 2007, when she was dean of San Diego State University's College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on Histogen. | + | Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb |
| − | <ref>{{REFweb | ||
|last= | |last= | ||
|first= | |first= | ||
| Line 11: | Line 10: | ||
|accessdate=2012-11-16 | |accessdate=2012-11-16 | ||
}}</ref> | }}</ref> | ||
| + | {{SEEALSO}} | ||
| + | * [[United States of America]] | ||
| + | {{LINKS}} | ||
| + | * {{REFweb | ||
| + | |url=https://www.lji.org/team-member/gail-naughton-ph-d-mba/ | ||
| + | |title=Gail K. Naughton, Ph.D., MBA | ||
| + | |last= | ||
| + | |first= | ||
| + | |init= | ||
| + | |publisher=La Jolla Institute for Imunology | ||
| + | |date= | ||
| + | |accessdate=2024-05-02 | ||
| + | }} | ||
| + | {{REF}} | ||
| + | |||
| + | {{DEFAULTSORT:Naughton, Gail K}} | ||
| − | + | [[Category:Person]] | |
| + | [[Category:Female]] | ||
[[Category:Financial gain]] | [[Category:Financial gain]] | ||
| Line 18: | Line 34: | ||
[[Category:From CircLeaks]] | [[Category:From CircLeaks]] | ||
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
| + | |||
| + | [[Category:USA]] | ||
[[de:{{FULLPAGENAME}}]] | [[de:{{FULLPAGENAME}}]] | ||
Latest revision as of 15:30, 2 May 2024
Gail K. Naughton, Ph.D., MBA, B.S., was president and COO of Advanced Tissue Sciences, which produced a living skin product call Dermagraft used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of Shire, a medical company based in Dublin, Ireland.
Naughton founded Histogen in 2007, when she was dean of San Diego State University's College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on Histogen.[1]
See also
External links
Gail K. Naughton, Ph.D., MBA
, La Jolla Institute for Imunology. Retrieved 2 May 2024.
References
- ↑ (5 September 2012).
U.S. Patent issued for Histogen's Novel Cell Growth Process
, Histogen. Retrieved 16 November 2012.